Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ETS domain-containing protein Elk-4 (ELK4) is a transcription factor in the ETS family and a member of the ternary complex factor (TCF) subfamily. ELK4 forms a ternary complex with serum response factor (SRF) at serum response elements, regulating the expression of immediate-early genes such as c-fos. It is involved in transmitting extracellular signals, particularly via MAPK1 and MAPK8 phosphorylation, to the nucleus, influencing gene expression related to cell proliferation, cell cycle, signal transduction, and immune cell activation. ELK4 has roles in normal physiological processes (e.g., thymocyte development, mast cell proliferation), as well as disease, especially cancer, where it can contribute to oncogenic processes through aberrant modulation of transcription, altered chromatin regulation, and direct interaction with oncogenic signaling pathways.
Modulation of transcriptional programs by regulating gene expression through ternary complex formation with SRF (serum response factor); Regulation of cell cycle and response to extracellular signals by modulation of immediate-early genes (such as Egr1) via the MAPK pathway
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ETS domain-containing protein Elk-4 (ELK4).